Search
Ascendis Pharma A/S
ASNDAdd to Watchlist
243.910USD
-7.160-2.85%
Close 07-31 16:00（ET）Quotes delayed by 15 min
16.14BMarket Cap
35.15P/E TTM
ASND Income Statement
You can find the annual or quarterly income statement of Ascendis Pharma A/S here for insights into the performance and operational efficiency of Ascendis Pharma A/S.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
How do I read Ascendis Pharma A/S's income statement on TradingKey?
Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.
What is the difference between quarterly and annual income statements?
A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.
What does YOY mean on the income statement page?
YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.
Which income statement metrics matter most when analyzing ASND stock?
Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.
What was Ascendis Pharma A/S's revenue at year end?
Ascendis Pharma A/S reported 854.80M in revenue for fiscal year 2025, up from 377.53M in the previous year.
How much revenue did Ascendis Pharma A/S report in the most recent quarter?
Ascendis Pharma A/S reported 289.14M in revenue for the most recent quarter, an increase of 153.66% year over year.
What was Ascendis Pharma A/S's net income for the year?
Ascendis Pharma A/S posted -270.68M in net income for fiscal year 2025.
How much net income did Ascendis Pharma A/S post in the last quarter?
Ascendis Pharma A/S reported 737.90M in net income for the latest quarter。
What was Ascendis Pharma A/S's annual operating profit?
Ascendis Pharma A/S's operating income was -161.75M for fiscal year 2025.
How is EPS related to the income statement?
EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.